Author:
Ninan Ipe,Kulkarni Shrinivas K
Reference36 articles.
1. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine;Bakshi;Psychopharmacology,1995
2. Baldessarini, R.J., 1990. Drugs and the treatment of psychiatric disorders. In: Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P. (Eds.), The Pharmacological Basis of Therapeutics, pp. 383–435.
3. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial;Beasely;Neuropsychopharmacology,1995
4. The selective 5-HT2A receptor antagonist MDL 100907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse—implications for psychosis;Carlsson;J. Neural Transm.,1995
5. Interactions between glutamatergic and monoaminergic systems within basal ganglia—implications for schizophrenia and Parkinson's disease;Carlsson;Trends Neurosci.,1990
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献